159
Views
17
CrossRef citations to date
0
Altmetric
Original Research

A prospective, multicenter, noninterventional study of Optive Plus® in the treatment of patients with dry eye: the prolipid study

, , , &
Pages 1147-1155 | Published online: 17 Jun 2014

References

  • BehrensADoyleJJSternLDysfunctional Tear Syndrome Study GroupDysfunctional tear syndrome: a Delphi approach to treatment recommendationsCornea200625890090717102664
  • International Dry Eye WorkShopReport of the International Dry Eye WorkShop (DEWS)Ocul Surf20075261204
  • NicholsKKPatient-reported symptoms in dry eye diseaseOcul Surf2006413714516900269
  • MiljanovićBDanaRSullivanDASchaumbergDAImpact of dry eye syndrome on vision-related quality of lifeAm J Ophthalmol2007143340941517317388
  • LiMGongLSunXChapinWJAnxiety and depression in patients with dry eye syndromeCurr Eye Res20113611721174591
  • BaudouinCAragonaPMessmerEMRole of hyperosmolarity in the pathogenesis and management of dry eye disease: proceedings of the OCEAN group meetingOcul Surf201311424625824112228
  • GotoETsengSCDifferentiation of lipid tear deficiency dry eye by kinetic analysis of tear interference imagesArch Ophthalmol2003121217318012583782
  • MurubeJNémethJHöhHThe triple classification of dry eye for practical clinical useEur J Ophthalmol200515666066716329048
  • BertaAThe differential diagnosis of the red eyeInt Ophthalmol200828Suppl 1S7S17
  • KnopEKnopNMillarTObataHSullivanDAThe international workshop on meibomian gland dysfunction: report of the subcommittee on anatomy, physiology, and pathophysiology of the meibomian glandInvest Ophthalmol Vis Sci20115241938197821450915
  • LeeSYTongLLipid-containing lubricants for dry eye: a systematic reviewOptom Vis Sci201289111654166123096494
  • PetricekIDry eyeInt Ophthalmol200828 suppl.1831
  • NicholsKKFoulksGNBronAJThe international workshop on meibomian gland dysfunction: executive summaryInvest Ophthalmol Vis Sci20115241922192921450913
  • Di PascualeMAGotoETsengSCSequential changes of lipid tear film after the instillation of a single drop of a new emulsion eye drop in dry eye patientsOphthalmology2004111478379115051213
  • KhanalSTomlinsonAPearceEISimmonsPAEffect of an oil-in-water emulsion on the tear physiology of patients with mild to moderate dry eyeCornea200726217518117251808
  • LempMACrewsLABronAJFoulksGNSullivanBDDistribution of aqueous-deficient and evaporative dry eye in a clinic-based patient cohort: a retrospective studyCornea201231547247822378109
  • BeardBJSimmonsPJVehigeJGMechanism of action of an advanced artificial tear formulationPresented at the Annual Meeting of the American Academy of OptometryOctober 12–15, 2011Boston, MA
  • SchiffmanRMChristiansonMDJacobsenGHirschJDReisBLReliability and validity of the Ocular Surface Disease IndexArch Ophthalmol2000118561562110815152
  • GarrettQSimmonsPAXuSCarboxymethylcellulose binds to human corneal epithelial cells and is a modulator of corneal epithelial wound healingInvest Ophthalmol Vis Sci20074841559156717389485
  • RajpalRKLoganLAKislanTPEvaluation of Optive™ in patients previously using Systane® for the treatment of dry eye signs and symptomsPoster presented at: the 5th International Conference on the Tear Film and Ocular Surface: Basic Science and Clinical relevanceSeptember 5–8, 2007Taormina, Italy
  • KaercherTBuchholzPKimmichFTreatment of patients with keratoconjunctivitis sicca with Optive: results of a multicenter, open-label observational study in GermanyClin Ophthalmol20093333919668542
  • GuillonMMaissaCHoSEvaluation of the effects on conjunctival tissues of Optive eyedrops over one month usageCont Lens Anterior Eye2010332939920227636
  • BaudouinCCochenerBPisellaPJRandomized, phase III study comparing osmoprotective carboxymethylcellulose with sodium hyaluronate in dry eye diseaseEur J Ophthalmol201222575176122287172
  • SternMEThe normal tear film and ocular surfacePflugfelderSCBeuermanRVVSternMEDry Eye and Ocular Surface DisordersNew York, NYMarcel-Dekker20044162
  • NicolaidesNKaitarantaJKRawdahTNMacyJIBoswellFMSmithREMeibomian gland studies: comparison of steer and human lipidsInvest Ophthalmol Vis Sci19812045225367194326
  • McCulleyJPShineWA compositional based model for the tear film lipid layerTrans Am Ophthalmol Soc1997957988 discussion 88–939440164
  • TiffanyJMThe normal tear filmDev Ophthalmol20084112018453758
  • SilvermanJJThe first three-layered tear substituteContacto1983271922
  • RiegerGLipid-containing eye drops: a step closer to natural tearsOphthalmologica199020142062122077458
  • GeerlingGTauberJBaudouinCThe international workshop on meibomian gland dysfunction: report of the subcommittee on management and treatment of meibomian gland dysfunctionInvest Ophthalmol Vis Sci20115242050206421450919
  • GotoEShimazakiJMondenYLow-concentration homogenized castor oil eye drops for noninflamed obstructive meibomian gland dysfunctionOphthalmology2002109112030203512414410
  • OgunniyiDSCastor oil: a vital industrial raw materialBioresour Technol20069791086109115919203
  • NoeckerREffects of common ophthalmic preservatives on ocular healthAdv Ther200118520521511783457
  • MaissaCAGuillonMBossardBThe effect of a new lipid-based eye drop and its interaction with the lipid layerPresented at: ARVO 2012May 6–10, 2012Fort Lauderdale, FL
  • ConnorCGOttenbreitRSchroederLKRabinJCNarayananSComparison of three commercially available tear substitutes designed for evaporative dry eye treatmentPresented at: ARVO 2013May 5–9, 2013Seattle, WA